In an effort to increase knowledge and understanding of the process of assuring data quality and validity in clinical trials, the IOM hosted a workshop to open a dialogue on the process to identify and discuss issues of mutual concern among industry, regulators, payers, and consumers. The presenters and panelists together developed strategies that could be used to address the issues that were identified. This IOM report of the workshop summarizes the present status and highlights possible strategies for making improvements to the education of interested and affected parties as well as facilitating future planning.
Institute of Medicine, Committee on Quality of Health Care in America, Committee on Quality of Health Care in A, Institute Of Medicine, Molla S. Donaldson, Janet M. Corrigan, Linda T. Kohn
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual, Board on the Health of Select Population, Institute Of Medicine, Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities
Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement, Committee for the Study of Health Conseq, Institute Of Medicine
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health, Board on Population Health and Public He, Institute Of Medicine
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Committee to Develop Methods Useful to t, Institute Of Medicine, Joseph Lipscomb
Institute of Medicine, Committee on Military Nutrition Research, Institute Of Medicine, Judith Grumstrup-Scott, Bernadette M. Marriott, Bernadette M Marriott